Bioinovacijos - Company finances
- The company is late in submitting financial data for the previous financial year.
- Latest financial data up to 2025-05-31.
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 0 | - | 64,013 | 138,200 | 283,806 | - | - |
| Profit before tax | 0 | -2,735 | -88,193 | -2,715 | 75,904 | -72,336 | -195,217 |
| Net profit | 0 | -2,735 | -88,193 | -2,715 | 75,251 | -72,336 | -195,217 |
| Equity | 2,500 | -235 | -88,428 | -91,143 | 13,921 | -58,415 | -253,632 |
| Liabilities | 0 | 10,153 | 358,720 | 383,111 | 324,899 | 335,410 | 350,183 |
| Non-current assets | 0 | 1,612 | 169,130 | 140,101 | 111,085 | 82,431 | 1,104 |
| Current assets | 2,500 | 8,306 | 101,162 | 151,867 | 227,735 | 194,564 | 95,447 |
| Total assets | 2,500 | 9,918 | 270,292 | 291,968 | 338,820 | 276,995 | 96,551 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | - | 3 | - |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | - | +115.9% | +105.4% | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -27.6% | -32.6% | -0.9% | 22.2% | -26.1% | -202.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | - | - | 540.6% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -137.8% | -2.0% | 26.5% | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -137.8% | -2.0% | 26.7% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 23.3 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 64,013 | 138,200 | 141,903 | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioinovacijos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-11 | 2025-04-10 | 2749.64 |
| 2025-02-10 | 2025-02-10 | 2802.41 |
| 2025-02-07 | 2025-02-09 | 2749.64 |
| 2025-01-22 | 2025-02-06 | 2802.41 |
| 2025-01-16 | 2025-01-21 | 2770.53 |
| 2025-01-10 | 2025-01-15 | 2025.30 |
| 2025-01-02 | 2025-01-09 | 2031.28 |
| 2024-12-22 | 2024-12-31 | 2031.28 |
| 2024-12-17 | 2024-12-20 | 2031.28 |
| 2024-11-18 | 2024-12-16 | 1286.05 |
| 2024-10-28 | 2024-11-17 | 540.82 |
| 2024-10-16 | 2024-10-27 | 730.77 |
| 2024-06-18 | 2024-07-02 | 1489.74 |
| 2024-06-05 | 2024-06-17 | 744.51 |
| 2024-05-21 | 2024-06-04 | 745.23 |
| 2024-05-16 | 2024-05-20 | 2220.95 |
| 2024-04-23 | 2024-05-15 | 1475.72 |
| 2024-04-16 | 2024-04-22 | 1454.65 |
| 2024-03-27 | 2024-04-15 | 709.42 |
| 2024-03-18 | 2024-03-26 | 745.23 |
| 2024-02-19 | 2024-03-07 | 1349.63 |
| 2024-01-31 | 2024-02-18 | 604.40 |
| 2024-01-23 | 2024-01-30 | 615.18 |
| 2024-01-16 | 2024-01-22 | 600.75 |
| 2023-12-18 | 2024-01-01 | 1173.16 |
| 2023-11-29 | 2023-12-17 | 572.41 |
| 2023-11-16 | 2023-11-28 | 600.75 |
| 2023-10-31 | 2023-11-05 | 146.09 |
| 2023-10-30 | 2023-10-30 | 544.07 |
| 2023-10-25 | 2023-10-29 | 611.20 |
| 2023-10-17 | 2023-10-24 | 600.75 |
| 2023-09-29 | 2023-10-11 | 593.94 |
| 2023-09-18 | 2023-09-28 | 600.75 |
| 2023-08-30 | 2023-08-30 | 353.80 |
| 2023-08-29 | 2023-08-29 | 551.78 |
| 2023-08-17 | 2023-08-28 | 600.75 |
| 2023-08-02 | 2023-08-07 | 509.57 |
| 2023-07-28 | 2023-08-01 | 514.03 |
| 2023-07-26 | 2023-07-27 | 510.30 |
| 2023-07-24 | 2023-07-25 | 514.09 |
| 2023-07-18 | 2023-07-23 | 510.30 |
| 2023-06-16 | 2023-06-25 | 609.55 |
| 2023-05-02 | 2023-05-04 | 2.28 |
| 2023-04-27 | 2023-04-28 | 2.28 |
| 2023-04-26 | 2023-04-26 | 599.74 |
| 2023-04-18 | 2023-04-25 | 597.46 |
| 2023-02-17 | 2023-02-28 | 422.08 |
| 2023-02-06 | 2023-02-06 | 85.13 |
| 2023-01-27 | 2023-02-03 | 85.13 |
| 2023-01-17 | 2023-01-26 | 100.00 |
| 2022-11-21 | 2022-12-06 | 0.03 |
| 2022-11-17 | 2022-11-18 | 0.03 |
| 2022-10-28 | 2022-11-09 | 0.02 |
| 2022-05-17 | 2022-05-29 | 668.93 |
| 2022-04-28 | 2022-05-16 | 337.17 |
| 2022-04-19 | 2022-04-27 | 331.76 |
| 2022-03-16 | 2022-03-17 | 292.57 |
| 2022-03-03 | 2022-03-15 | 244.63 |
| 2022-03-01 | 2022-03-02 | 334.01 |
| 2022-02-25 | 2022-02-28 | 450.03 |
| 2022-02-17 | 2022-02-24 | 491.47 |
| 2022-01-31 | 2022-02-16 | 159.71 |
| 2022-01-28 | 2022-01-30 | 201.07 |
| 2022-01-24 | 2022-01-27 | 203.70 |
| 2022-01-18 | 2022-01-23 | 406.61 |
| 2021-12-16 | 2022-01-17 | 202.91 |
| 2021-11-05 | 2021-11-15 | 0.51 |
Bioinovacijos - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-24 | 2025-07-21 | 1.38 |
| 2025-06-22 | 2025-06-23 | 249.81 |
| 2025-06-20 | 2025-06-21 | 249.74 |
| 2025-06-19 | 2025-06-19 | 249.67 |
| 2025-06-18 | 2025-06-18 | 249.6 |
| 2025-06-17 | 2025-06-17 | 249.53 |
| 2025-06-14 | 2025-06-16 | 247.29 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.